Investors on Wall Street are cautiously optimistic, reacting to a mix of weaker-than-expected economic data and renewed hopes for two interest rate cuts by the end of 2025. Big cap indices are trading in the green (S&P500: +0.18%, Nasdaq: +0.2%, DJIA: +0.2%), while small caps are underperforming due to discouraging outlooks from the latest ISM reports (Russell 2000: 0.13%).
Adding to the cautious sentiment, the ADP employment report showed a sharp slowdown in job creation. Only 37,000 new private-sector jobs were added in May—well below the expected 110,000 and nearly 50% lower than April’s figure. This signals weakening hiring activity amid uncertain economic growth.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appMeanwhile, the ISM Services Index also pointed to a cooling economy. The index fell to 49.9 in May, below the expected 52, indicating contraction in the services sector. Price pressures continue to mount, largely due to the unsettling tariff expectations.
Together, these data points have increased market bets that the Federal Reserve may intervene with interest rate cuts to avoid a potential recession. This sentiment is echoed in bond markets, where the yield on the 10-year U.S. Treasury has fallen by 1.6%.
US2000 (D1)
Small-cap stocks are under pressure today, dragged down by disappointing ISM data. The Russell 2000 stands out as the only major index in the red, reflecting investor concerns over the economic outlook for smaller companies.
Despite a strong start to the day, the index failed to hold its gains and slipped back to the 2,100 level—a key resistance point previously tested in late March and mid-May. Ongoing producer price pressures and uncertainty surrounding tariffs are weighing heavily on smaller firms. These headwinds are now being reflected technically, with the exponential moving averages (EMAs) for the index showing signs of flattening—an indicator of weakening momentum.
Source: xStation5
Company news:
-
AnaptysBio shares are down 12% in spite of premarket gains fueled by the news that Phase 2b trial data showed its drug rosnilimab delivered JAK-like efficacy in moderate-to-severe rheumatoid arthritis. Patients achieved low disease activity, remission on the CDAI, and ACR70 responses over six months, with effects lasting two months off treatment.
-
Chart Industries (GTLS.US) and Flowserve (FLS.US) agreed to an all-stock merger valuing the combined company at ~$19B. Chart holders will get 3.165 Flowserve shares per share owned and hold 53.5% of the merged firm. The deal promises $300M in synergies and EPS accretion in year one, with closing expected in Q4. Nevertheless both stocks are currently losing around 4%.
-
Couchbase is up 4,3% despite issuing a rather cautious Q2 outlook despite strong Q1 results. Annual recurring revenue grew 21% to $252.1M, beating estimates, and driven by Capella cloud adoption and strategic wins. While Q1 revenue and earnings topped forecasts, guidance for Q2 revenue was soft, reflecting prudence amid macro uncertainty.
-
Guidewire (GWRE.US) shares surged 19% after raising full-year revenue guidance above estimates, driven by strong cloud migration execution, new deals, and cost management. Q3 revenue rose 22% YoY to $293.5M, with adjusted EPS beating at 88c vs. 46c expected. Analysts praised its growing market share among large carriers and raised price targets amid a robust sales pipeline.
-
Hewlett Packard Enterprise (HPE.US) shares rose 0.3% following Q2 results that topped expectations with broad-based strength. Revenue rose 5.9% to $7.63B, led by solid growth in Servers (+5.6%), Hybrid Cloud (+13%), and Intelligent Edge (+7%). The company raised the low end of its full-year EPS forecast and sees continued revenue growth of 7–9% in constant currency. Despite modest AI-related revenue and mixed guidance, analysts noted improved server execution and solid margin performance, with Q2 EPS beating consensus at $0.38 vs. $0.33 expected.
-
Snowflake (SNOW.US) shares are up 0.5% premarket after its Summit event showcased a robust AI-driven product roadmap, including advancements in core analytics, support for unstructured workloads, and accelerated AI capabilities. Analysts noted strong enterprise interest, streamlined go-to-market strategies, and hiring momentum as signs of durable growth. They were also positive on the entire data investment cycle.
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.